BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that Joep Muijrers, Ph.D., Chief Financial Officer at PureTech Health, will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, June 6, at 9:30AM EDT.
About PureTech Health
PureTech Health (PRTC.L) is an
advanced, clinical-stage biopharmaceutical company developing novel
medicines targeting serious diseases that result from dysfunctions in
the nervous, immune, and gastrointestinal systems (brain-immune-gut or
the “BIG” axis), which together represent the adaptive human systems.
PureTech Health is at the forefront of understanding and addressing the
biological processes and crosstalk associated with the BIG axis. By
harnessing this emerging field of human biology, PureTech Health is
pioneering new categories of medicine with the potential to have great
impact on people with serious diseases. PureTech Health is advancing a
rich pipeline of innovative therapies that includes two pivotal stage
programs, multiple human proof-of-concept studies and a number of early
clinical and pre-clinical programs. PureTech’s research and development
pipeline has been advanced in collaboration with some of the world’s
leading scientific experts, who along with PureTech's team of biopharma
pioneers, entrepreneurs and seasoned Board, identify, invent, and
clinically de-risk new medicines. With this experienced team pursuing
cutting edge science, PureTech Health is building the biopharma company
of the future focused on improving and extending the lives of people
with serious disease. For more information, visit www.puretechhealth.com or
connect with us on Twitter @puretechh.
Forward Looking Statement
This press release contains
statements that are or may be forward-looking statements, including
statements that relate to the company's future prospects, developments
and strategies. The forward-looking statements are based on current
expectations and are subject to known and unknown risks and
uncertainties that could cause actual results, performance and
achievements to differ materially from current expectations, including,
but not limited to, those risks and uncertainties described in the risk
factors included in the regulatory filings for PureTech Health plc.
These forward-looking statements are based on assumptions regarding the
present and future business strategies of the company and the
environment in which it will operate in the future. Each forward-looking
statement speaks only as at the date of this press release. Except as
required by law and regulatory requirements, neither the company nor any
other party intends to update or revise these forward-looking
statements, whether as a result of new information, future events or
otherwise.
